How Sponsors Can Take Advantage of the Major Changes in ICH E6 (R3) To Maximize Trial Succes
The latest revision of the International Council for Harmonisation’s Good Clinical Practice (GCP) guidelines, ICH E6 (R3), introduces several changes aimed at improving the quality, efficiency, and patient-centricity of clinical trials. For sponsors of clinical trials, these changes present unique opportunities to optimize trial designs, reduce costs, enhance data integrity, and improve trial outcomes. The…